Page 5 - Hepalys Pharma Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hepalys Pharma, Inc. is a new company created by Catalys Pacific and in which Inventiva has a 30% ownership position. Under the exclusive licensing agreement, Inventiva will receive a $10 million upfront payment, and is

New yorkUnited statesSan franciscoSouth koreaSouth koreansSouth koreanHepalys pharmaNonliver comorbiditiesCatalys pacificInnovation fundHepalys pharma inc weMitsubishi ufjExchange commission onHepalys pharma incLong island cityGreater china